Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Sepax Technologies
AddedFeb 13, 2024
UpdatedJun 18, 2026
Sepax Technologies

Sepax Technologies

Series D

Sepax Technologies: High-performance liquid chromatography equipment and consumables manufacturer.

HQ
Newark, DE, US
Founded
2002
Overview
Compare
Fundraising
Employees
Website

Founded in 2002, Sepax Technologies Inc. is dedicated to advancing high-performance liquid chromatography (HPLC) through the development and manufacturing of consumables, bulk media, and equipment. The company's core mission is to provide innovative and reliable chromatography solutions that enhance the efficiency and accuracy of scientific research and industrial processes. Sepax offers a wide range of products including column screening, method development, preparative separation, purification, and surface coating services, catering primarily to the pharmaceutical, biotechnology, and chemical industries.

Sepax Technologies has garnered attention for its robust portfolio and commitment to quality, attracting notable investors and industry experts. The company has achieved significant milestones such as the development of proprietary surface coating technologies and the introduction of advanced HPLC columns like Unix and Proteomix. Sepax's impact is evident in its widespread adoption by leading research institutions and corporations, solidifying its reputation as a key player in the chromatography market.

Sepax Technologies - Similar Companies

Sepragen logo

Sepragen

sepragen.com

Zepteon logo

Zepteon

zepteon.com

Waters logo

Waters

Agilent Technologies logo

Agilent Technologies

agilent.com

H2Optx logo

H2Optx

Millennial Scientific logo

Millennial Scientific

SmartFlow Technologies logo

SmartFlow Technologies

smartflow-tech.com

Laxco logo

Laxco

laxcoinc.com

Purist logo

Purist

puristllc.com

DPX Technologies logo

DPX Technologies

CC Biotech logo

CC Biotech

BioNex Solutions logo

BioNex Solutions

Practichem logo

Practichem

practichem.com

Spheryx logo

Spheryx

spheryx.solutions

Q Biotech logo

Q Biotech

q-biotech.com

Sepax Technologies - Quick Facts

Who are Sepax Technologies' competitors?

Companies similar to Sepax Technologies include Sepragen, Zepteon, Waters and Agilent Technologies.

When was Sepax Technologies founded?

Sepax Technologies was founded in 2002.

Where is Sepax Technologies' headquarters located?

Sepax Technologies' headquarters is located in Newark, DE, US.

When was Sepax Technologies' last funding round?

Sepax Technologies' most recent funding round was for $500M (USD) in November 2021.

How much has Sepax Technologies raised to-date?

As of Nov 15, 2021, Sepax Technologies has raised a total of $700M (USD).

How many employees does Sepax Technologies have?

Sepax Technologies has 175 employees as of Feb 4, 2024.

Sepax Technologies - Classification

Industry
  • Hardware
Geographic Exposure
  • Global
Revenue
  • Software
  • Transactional
Customer
  • Enterprise
  • Small Business
Main Product
  • Consumables
  • HPLC Equipment
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 8690Other human health activities
Show 19 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified